Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

BACKGROUND: Characterization of the mesenchymal stromal cell (MSC) safety profile is important as this novel therapy continues to be evaluated in clinical trials for various inflammatory conditions. Due to an increase in published randomized controlled trials (RCTs) from 2012–2019, we performed an u...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Mary, Mei, Shirley H.J., Wolfe, Dianna, Champagne, Josée, Fergusson, Dean, Stewart, Duncan J., Sullivan, Katrina J., Doxtator, Emily, Lalu, Manoj, English, Shane W., Granton, John, Hutton, Brian, Marshall, John, Maybee, Alies, Walley, Keith R., Santos, Claudia Dos, Winston, Brent, McIntyre, Lauralyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970160/
https://www.ncbi.nlm.nih.gov/pubmed/31989101
http://dx.doi.org/10.1016/j.eclinm.2019.100249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970160/
https://www.ncbi.nlm.nih.gov/pubmed/31989101
http://dx.doi.org/10.1016/j.eclinm.2019.100249

Ejemplares similares